Nikolaus Trede

Company: Century Therapeutics

Job title: Senior Vice President & Head of Clinical Development

Seminars:

Optimizing Engineered Stealth Features for Allogeneic Cell Therapies 2:00 pm

Comprehensive allo-evasion engineering addressing both cellular and humoral allo-rejection mechanisms: HLA knock-out to prevent T-cell rejection HLA class I surrogate overexpression and TASR technology to prevent NK cell rejection IdeS to degrade pre-existing or de novo generated antibodies directed to the product Sharing preclinical and clinical insights of this approach in NHL and autoimmune diseaseRead more

day: Day 1 - Track A - PM

Panel Discussion: Evaluating NK Treatment Regiments in Autoimmune Patients to Maximize Treatment Outcomes 3:15 pm

Discussing patient treatment regiments and pre-treatment procedures in an autoimmune setting Do the same measures such as lymphodepletion need to be applied to autoimmune patients? What dosing regiment may be most beneficial for autoimmune patients?  Is it feasible to dose autoimmune patients several times?Read more

day: Pre-Conference Focus Day